Emergency Medicine Pulmonary Embolism Testing Multicentre Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDr. Kerstin de Wit

About this trial

It is important to diagnose pulmonary embolism in a timely manner to prevent death and long-term disability. More than half a million people (4-5% of emergency department patients) are tested for pulmonary embolism, although the positive rate is low. Imaging for PE testing exposes patients to radiation, is expensive, adds time to the emergency visit, and can lead to a false positive diagnoses. Existing protocols aimed at reducing unnecessary pulmonary embolism imaging are complex and seldom used by emergency physicians. Too many patients undergo unnecessary pulmonary embolism imaging.

A new tool (called Adjust-Unlikely) could safely reduce pulmonary embolism imaging in Canada. A research group composed of researchers, emergency physicians, and patients developed the Adjust-Unlikely clinical decision rule: a rule which has been customized for emergency physicians and emergency patients. Adjust-Unlikely is highly sensitive at the bedside, meaning there are very few false negative results.

The study aim is to prospectively validate Adjust-Unlikely pulmonary embolism testing in emergency patients with suspected pulmonary embolism.

Eligibility criteria

Qualifiers

Emergency department patient who is tested by an emergency physician for PE

Disqualifiers

Patient is < 18 years of age

No documentation of whether PE is the most likely diagnosis

D-dimer is not tested or else not resulted during the emergency visit

The D-dimer level is known before documentation of whether PE is the most likely diagnosis

Trial design

Treatments tested in this trial

  • Adjust-Unlikely

Treatment groups

4,000 Participants
are divided into 1 treatment group

Sponsors and collaborators

Dr. Kerstin de Wit

Lead sponsor

Queen's University

Sponsor institution

Canadian Institutes of Health Research (CIHR)

Collaborator